Summary
Stereotactic body radiotherapy (SBRT) is a treatment option for patients with non-small cell lung cancer (NSCLC) who are not eligible for surgical intervention. The staging workup for patients with NSCLC receiving stereotactic SBRT requires an initial positron emission tomographic (PET) imaging. This article analyzes the use of invasive mediastinal staging methods compared to PET imaging alone in patients with NSCLC.
- Oncology Clinical Trials
- Respiratory Cancers
- Radiology
- Cancer
- Radiation Therapy
- Oncology Clinical Trials
- Respiratory Cancers
- Radiology
- Cancer
- Oncology
- Radiation Therapy
- © 2014 MD Conference Express®
Tools
Invasive Mediastinal Staging is Not Necessary for Early-Stage NSCLC before SBRT
Permalink:
Table of contents
Cited By...
- No citing articles found.